financetom
Business
financetom
/
Business
/
Valero Energy reports lower quarterly profit on weak refining margins
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Valero Energy reports lower quarterly profit on weak refining margins
Nov 2, 2024 2:14 AM

(Reuters) -Refiner Valero Energy posted a 86% slump in third-quarter profit on Thursday on falling refining margins, but managed to beat Wall Street expectations.

The San Antonio, Texas-based refiner reported net income attributable to stockholders of $364 million, or $1.14 per share, for the three months ended Sept. 30, below $2.6 billion, or $7.49 per share, last year in the same quarter.

However, data compiled by LSEG showed analysts had expected a profit of 98 cents.

The company's refining margins stood at $2.41 billion in the quarter, compared with $5.41 billion last year.

Refiners globally have seen a drop in profitability on soft consumer and industrial demand, especially in China, because of slowing economic growth and the rising penetration of electric vehicles.

U.S. refinery margins, measured by the 3-2-1 crack spread, dipped to $14.28 in mid-September, the lowest since early 2021, on lackluster fuel demand.

Energy majors like Exxon Mobil, BP and Shell had said earlier this month that they expected weaker refining margins to weigh on their earnings in the third quarter.

Valero's refining segment reported operating income of $565 million for the third quarter, compared with $3.4 billion a year earlier.

Revenue came in at $32.87 billion, compared with estimates of $31.13 billion, partly on higher per sales volumes for ethanol and renewable diesel.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Amphastar Pharmaceuticals Gains US FDA Approval for Generic Bronchospasm Drug
Amphastar Pharmaceuticals Gains US FDA Approval for Generic Bronchospasm Drug
May 22, 2024
10:17 AM EDT, 05/22/2024 (MT Newswires) -- Amphastar Pharmaceuticals ( AMPH ) said Wednesday the US Food and Drug Administration has approved its Abbreviated New Drug Application for albuterol sulfate inhalation aerosol to treat bronchospasm in patients four years and older. An Abbreviated New Drug Application is filed with the FDA to gain approval for marketing a generic drug and...
Samsara, Carahsoft Partner to Enhance Safety, Efficiency in Public Fleet Management
Samsara, Carahsoft Partner to Enhance Safety, Efficiency in Public Fleet Management
May 22, 2024
10:16 AM EDT, 05/22/2024 (MT Newswires) -- Samsara (IOT) and Carahsoft Technology have partnered to improve safety and efficiency in public fleet management, the companies said Wednesday. Financial details of the partnership weren't provided. They said Samsara's technology solutions will be available to the public sector through Carahsoft's reseller partners and National Association of State Procurement Officials ValuePoint and Omnia...
BRIEF-Experian Acquires Strategic Stake In Reward
BRIEF-Experian Acquires Strategic Stake In Reward
May 22, 2024
May 22 (Reuters) - REWARD: * EXPERIAN ACQUIRES STRATEGIC STAKE IN REWARD * REWARD: KASHIF ASLAM APPOINTED TO REWARD BOARD OF DIRECTORS WITH IMMEDIATE EFFECT Source text for Eikon: Further company coverage: ...
Hollysys Automation Technologies CEO Changli Wang Sells Shares
Hollysys Automation Technologies CEO Changli Wang Sells Shares
May 22, 2024
10:15 AM EDT, 05/22/2024 (MT Newswires) -- Hollysys Automation Technologies ( HOLI ) Chief Executive Changli Wang has sold roughly 1.1 million of the company's ordinary shares, according to a Tuesday filing with the US Securities and Exchange Commission. Wang notified the company that his recent sale of shares was solely for his own personal financial planning needs, Hollysys said...
Copyright 2023-2026 - www.financetom.com All Rights Reserved